An update on the pharmacological management of endometriosis

Expert Opinion on Pharmacotherapy

Volumn 14, Issue 3, 2013, Pages 291-305

  Streuli, Isabelle ^a   De Ziegler, Dominique ^a   Santulli, Pietro ^a   Marcellin, Louis ^a   Borghese, Bruno ^a   Batteux, Frédéric ^a   Chapron, Charles ^a,b  

^a HÔTEL DIEU   (France)

^b INSTITUT COCHIN   (France)

Author keywords

Endometriosis; Hormonal treatments; Infertility; Non hormonal treatments; Pain

Indexed keywords

ANGIOGENESIS INHIBITOR; AROMATASE INHIBITOR; CONTRACEPTIVE AGENT; CYPROTERONE ACETATE; CYPROTERONE ACETATE PLUS ETHINYLESTRADIOL; DANAZOL; DESOGESTREL; DESOGESTREL PLUS ETHINYLESTRADIOL; DIENOGEST; DYDROGESTERONE; ESTROGEN; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; GANIRELIX; GESTAGEN; GONADORELIN AGONIST; GOSERELIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEUPRORELIN; LEVONORGESTREL; MEDROXYPROGESTERONE; MEDROXYPROGESTERONE ACETATE; NONSTEROID ANTIINFLAMMATORY AGENT; NORETHISTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; PENTOXIFYLLINE; PROGESTERONE RECEPTOR MODULATOR; TRIPTORELIN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNINDEXED DRUG;

ADULT DISEASE; ANALGESIA; BONE ATROPHY; CHILDHOOD DISEASE; CLINICAL EFFECTIVENESS; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DYSMENORRHEA; DYSPAREUNIA; DYSURIA; ENDOMETRIOSIS; ENDOMETRIUM TUMOR; FEMALE FERTILITY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HEADACHE; HIRSUTISM; HORMONAL CONTRACEPTION; HORMONAL THERAPY; HOT FLUSH; HUMAN; METRORRHAGIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL CONTRACEPTION; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PELVIS PAIN SYNDROME; PROSTATE CANCER; RECURRENT DISEASE; REVIEW; TRANSVAGINAL ECHOGRAPHY; UTERUS BLEEDING; VAGINAL DRYNESS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CONTRACEPTIVES, ORAL, COMBINED; ENDOMETRIOSIS; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; PAIN; RECURRENCE;

EID: 84873367900     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2013.767334     Document Type: Review

References (129)

1. Bulun SE. Endometriosis. N Engl J Med 2009;360:268-79
2. de Ziegler D, Borghese B, Chapron C. Endometriosis and infertility: Pathophysiology and management. Lancet 2010;376:730-8
3. Fauconnier A, Chapron C. Endometriosis and pelvic pain: Epidemiological evidence of the relationship and implications. Hum Reprod Update 2005;11:595-606 (Pubitemid 41631309)
4. Sampson JA. Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation. Am J Pathol 1927 ;3:93-110 ; 43
5. Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am 1997;24:235-58 (Pubitemid 27225159)
6. Chapron C, Pietin-Vialle C, Borghese B, et al. Associated ovarian endometrioma is a marker for greater severity of deeply infiltrating endometriosis. Fertil Steril 2009;92:453-7
7. Chapron C, Bourret A, Chopin N, et al. Surgery for bladder endometriosis: Long-Term results and concomitant management of associated posterior deep lesions. Hum Reprod 2010;25:884-9
8. Koninckx PR, Meuleman C, Demeyere S, et al. Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil Steril 1991;55:759-65
9. Ichida M, Gomi A, Hiranouchi N, et al. A case of cerebral endometriosis causing catamenial epilepsy. Neurology 1993;43:2708-9 (Pubitemid 24004576)
10. Augoulea A, Lambrinoudaki I, Christodoulakos G. Thoracic endometriosis syndrome. Respiration 2008;75:113-19
11. May KE, Villar J, Kirtley S, et al. Endometrial alterations in endometriosis: A systematic review of putative biomarkers. Hum Reprod Update 2011;17:637-53
12. Abrao MS, Podgaec S, Dias JA Jr, et al. Deeply infiltrating endometriosis affecting the rectum and lymph nodes. Fertil Steril 2006;86:543-7 (Pubitemid 44307031)
13. Noel JC, Chapron C, Fayt I, et al. Lymph node involvement and lymphovascular invasion in deep infiltrating rectosigmoid endometriosis. Fertil Steril 2008;89:1069-72 (Pubitemid 351671720)
14. Fedele L, Bianchi S, Zanconato G, et al. Is rectovaginal endometriosis a progressive diseasë Am J Obstet Gynecol 2004;191:1539-42
15. Brosens IA. Endometriosis-A disease because it is characterized by bleeding. Am J Obstet Gynecol 1997;176:263-7
16. Vercellini P. Endometriosis: What a pain it is. Semin Reprod Endocrinol 1997;15:251-61 (Pubitemid 27500173)
17. Anaf V, Simon P, El Nakadi I, et al. Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Hum Reprod 2000;15:1744-50 (Pubitemid 30636063)
18. Kinkel K, Frei KA, Balleyguier C, et al. Diagnosis of endometriosis with imaging: A review. Eur Radiol 2006;16:285-98 (Pubitemid 43149627)
19. Garcia-Velasco JA, Somigliana E. Management of endometriomas in women requiring IVF: To touch or not to touch. Hum Reprod 2009;24:496-501
20. Abrao MS, Goncalves MO, Dias JA Jr, et al. Comparison between clinical examination, transvaginal sonography and magnetic resonance imaging for the diagnosis of deep endometriosis. Hum Reprod 2007;22:3092-7 (Pubitemid 351696760)
21. Saccardi C, Cosmi E, Borghero A, et al. Ultrasound Obstet Gynecol 2012;40(4):464-9
22. Piketty M, Chopin N, Dousset B, et al. Preoperative work-up for patients with deeply infiltrating endometriosis: Transvaginal ultrasonography must definitely be the first-Line imaging examination. Hum Reprod 2009;24:602-7
23. Vercellini P, Pietropaolo G, De Giorgi O, et al. Reproductive performance in infertile women with rectovaginal endometriosis: Is surgery worthwhilë Am J Obstet Gynecol 2006;195:1303-10 (Pubitemid 44635367)
24. Vercellini P, Crosignani PG, Abbiati A, et al. The effect of surgery for symptomatic endometriosis: The other side of the story. Hum Reprod Update 2009;15:177-88
25. Dousset B, Leconte M, Borghese B, et al. Complete surgery for low rectal endometriosis: Long-Term results of a 100-Case prospective study. Ann Surg 2010;251:887-95
26. Cheong Y, Tay P, Luk F, et al. Laparoscopic surgery for endometriosis: How often do we need to re-operatë J Obstet Gynaecol 2008;28:82-5 (Pubitemid 351220613)
27. Garry R. The effectiveness of laparoscopic excision of endometriosis. Curr Opin Obstet Gynecol 2004;16:299-303 (Pubitemid 41015800)
28. Somigliana E, Chiodini A, Odorizzi MP, et al. The therapy of endometriosis. New prospects. Minerva Ginecol 2003;55:15-23
29. Weir E, Mustard C, Cohen M, et al. Endometriosis: What is the risk of hospital admission, readmission, and major surgical interventioñJ Minim Invasive Gynecol 2005;12:486-93 (Pubitemid 41758422)
30. Chapron C, Santulli P, de Ziegler D, et al. Ovarian endometrioma: Severe pelvic pain is associated with deeply infiltrating endometriosis. Hum Reprod 2012;27:702-11
31. Hachisuga T, Kawarabayashi T. Histopathological analysis of laparoscopically treated ovarian endometriotic cysts with special reference to loss of follicles. Hum Reprod 2002;17:432-5 (Pubitemid 34168453)
32. Hirokawa W, Iwase A, Goto M, et al. The post-operative decline in serum anti-Mullerian hormone correlates with the bilaterality and severity of endometriosis. Hum Reprod 2011;26:904-10
33. Somigliana E, Ragni G, Benedetti F, et al. Does laparoscopic excision of endometriotic ovarian cysts significantly affect ovarian reservë Insights from IVF cycles. Hum Reprod 2003;18:2450-3 (Pubitemid 37427830)
34. Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: A systematic review and meta-Analysis. J Clin Endocrinol Metab 2012;97:3146-54
35. Streuli I, de Ziegler D, Gayet V, et al. In women with endometriosis anti-Mullerian hormone levels are decreased only in those with previous endometrioma surgery. Hum Reprod 2012;27:3294-303
36. Fedele L, Parazzini F, Radici E, et al. Buserelin acetate versus expectant management in the treatment of infertility associated with minimal or mild endometriosis: A randomized clinical trial. Am J Obstet Gynecol 1992;166:1345-50
37. Fedele L, Bianchi S, Arcaini L, et al. Buserelin versus danazol in the treatment of endometriosis-Associated infertility. Am J Obstet Gynecol 1989;161:871-6 (Pubitemid 19266187)
38. Fraser IS, Shearman RP, Jansen RP, et al. A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol. Aust NZ J Obstet Gynaecol 1991;31:158-63
39. Henzl MR, Corson SL, Moghissi K, et al. Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial. N Engl J Med 1988;318:485-9 (Pubitemid 18054295)
40. Rotondi M, Labriola D, Ammaturo FP, et al. Depot leuprorelin acetate versus danazol in the treatment of infertile women with symptomatic endometriosis. Eur J Gynaecol Oncol 2002;23:523-6 (Pubitemid 36069995)
41. Sallam HN, Garcia-Velasco JA, Dias S, et al. Long-Term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev 2006;CD004635
42. de Ziegler D, Gayet V, Aubriot FX, et al. Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes. Fertil Steril 2010;94:2796-9
43. Vercellini P, Somigliana E, Vigano P, et al. Surgery for endometriosis-Associated infertility: A pragmatic approach. Hum Reprod 2009;24:254-69
44. Marjoribanks J, Proctor M, Farquhar C, et al. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev 2010;CD001751
45. Wong CL, Farquhar C, Roberts H, et al. Oral contraceptive pill as treatment for primary dysmenorrhoea. Cochrane Database Syst Rev 2009;CD002120
46. Chapron C, Borghese B, Streuli I, et al. Markers of adult endometriosis detectable in adolescence. J Pediatr Adolesc Gynecol 2011;24:S7-12
47. Chapron C, Souza C, Borghese B, et al. Oral contraceptives and endometriosis: The past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis. Hum Reprod 2011;26:2028-35
48. Sagsveen M, Farmer JE, Prentice A, et al. Gonadotrophin-releasing hormone analogues for endometriosis: Bone mineral density. Cochrane Database Syst Rev 2003;CD001297
49. Surrey ES. Gonadotropin-releasing hormone agonist and add-back therapy: What do the data show? Curr Opin Obstet Gynecol 2010;22:283-8
50. Brown J, Pan A, Hart RJ. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev 2010;CD008475
51. Brown J, Kives S, Akhtar M. Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev 2012;3:CD002122
52. Overton CE, Lindsay PC, Johal B, et al. A randomized, double-blind, placebo-Controlled study of luteal phase dydrogesterone (Duphaston) in women with minimal to mild endometriosis. Fertil Steril 1994;62:701-7 (Pubitemid 24307560)
53. Telimaa S, Puolakka J, Ronnberg L, et al. Placebo-Controlled comparison of danazol and high-Dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecol Endocrinol 1987;1:13-23
54. McCormack PL. Dienogest: A review of its use in the treatment of endometriosis. Drugs 2010;70:2073-88
55. Klipping C, Duijkers I, Remmers A, et al. Ovulation-inhibiting effects of dienogest in a randomized, dose-Controlled pharmacodynamic trial of healthy women. J Clin Pharmacol 2011
56. Strowitzki T, Faustmann T, Gerlinger C, et al. Dienogest in the treatment of endometriosis-Associated pelvic pain: A 12-week, randomized, double-blind, placebo-Controlled study. Eur J Obstet Gynecol Reprod Biol 2010;151:193-8
57. Strowitzki T, Marr J, Gerlinger C, et al. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: A 24-week, randomized, multicentre, open-Label trial. Hum Reprod 2010;25:633-41
58. Strowitzki T, Marr J, Gerlinger C, et al. Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis. Int J Gynaecol Obstet 2012;117:228-33
59. Vercellini P, Pietropaolo G, De Giorgi O, et al. Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-Dose norethindrone acetate. Fertil Steril 2005;84:1375-87 (Pubitemid 41571884)
60. Vercellini P, De Giorgi O, Mosconi P, et al. Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis. Fertil Steril 2002;77:52-61 (Pubitemid 34093893)
61. Fedele L, Arcaini L, Bianchi S, et al. Comparison of cyproterone acetate and danazol in the treatment of pelvic pain associated with endometriosis. Obstet Gynecol 1989;73:1000-4 (Pubitemid 19143838)
62. ClinicalTrials registry and results database (US National Institutes database). Available from: Www. ClinicalTrials.gov
63. Luukkainen T, Lahteenmaki P, Toivonen J. Levonorgestrel-releasing intrauterine device. Ann Med 1990;22:85-90 (Pubitemid 20193529)
64. Hidalgo M, Bahamondes L, Perrotti M, et al. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception 2002;65:129-32 (Pubitemid 34258502)
65. Tanmahasamut P, Rattanachaiyanont M, Angsuwathana S, et al. Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: A randomized controlled trial. Obstet Gynecol 2012;119:519-26
66. Bayoglu Tekin Y, Dilbaz B, Altinbas SK, et al. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: Levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue. Fertil Steril 2011;95:492-6
67. Petta CA, Ferriani RA, Abrao MS, et al. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod 2005;20:1993-8 (Pubitemid 40932389)
68. Wong AY, Tang LC, Chin RK. Levonorgestrel-releasing intrauterine system (Mirena) and Depot medroxyprogesterone acetate (Depoprovera) as long-Term maintenance therapy for patients with moderate and severe endometriosis: A randomised controlled trial. Aust NZ J Obstet Gynaecol 2010;50:273-9
69. Lockhat FB, Emembolu JO, Konje JC. The evaluation of the effectiveness of an intrauterine-Administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease. Hum Reprod 2004;19:179-84 (Pubitemid 38072029)
70. Vercellini P, Frontino G, De Giorgi O, et al. Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: A pilot study. Fertil Steril 2003;80:305-9 (Pubitemid 36959787)
71. Fedele L, Bianchi S, Zanconato G, et al. Use of a levonorgestrel- releasing intrauterine device in the treatment of rectovaginal endometriosis. Fertil Steril 2001;75:485-8 (Pubitemid 32175660)
72. Vercellini P, Frontino G, De Giorgi O, et al. Continuous use of an oral contraceptive for endometriosis-Associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril 2003;80:560-3 (Pubitemid 37102866)
73. Vercellini P, Barbara G, Somigliana E, et al. Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis. Fertil Steril 2010;93:2150-61
74. Harada T, Momoeda M, Taketani Y, et al. Low-Dose oral contraceptive pill for dysmenorrhea associated with endometriosis: A placebo-Controlled, double-blind, randomized trial. Fertil Steril 2008;90:1583-8
75. Vercellini P, Trespidi L, Colombo A, et al. A gonadotropin-releasing hormone agonist versus a low-Dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril 1993;60:75-9 (Pubitemid 23198922)
76. Selak V, Farquhar C, Prentice A, et al. Danazol for pelvic pain associated with endometriosis. Cochrane Database Syst Rev 2007;CD000068
77. Marjoribanks J, Proctor ML, Farquhar C. Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea. Cochrane Database Syst Rev 2003;CD001751
78. Kauppila A, Ronnberg L. Naproxen sodium in dysmenorrhea secondary to endometriosis. Obstet Gynecol 1985;65:379-83 (Pubitemid 15134665)
79. Allen C, Hopewell S, Prentice A, et al. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev 2009;CD004753
80. Struthers RS, Nicholls AJ, Grundy J, et al. Suppression of gonadotropins and estradiol in premenopausal women by oral administration of the nonpeptide gonadotropin-releasing hormone antagonist elagolix. J Clin Endocrinol Metab 2009;94:545-51
81. GlobaldData Expert analysis of markets and pipeline pharmaceutical products. Available from: Www.globaldata.com
82. Bulun SE, Sharda G, Rink J, et al. Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast. J Clin Endocrinol Metab 1996;81:1273-7 (Pubitemid 26084463)
83. Colette S, Lousse JC, Defrere S, et al. Absence of aromatase protein and mRNA expression in endometriosis. Hum Reprod 2009;24:2133-41
84. Soysal S, Soysal ME, Ozer S, et al. The effects of post-Surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: A prospective randomized trial. Hum Reprod 2004;19:160-7 (Pubitemid 38072026)
85. Alborzi S, Hamedi B, Omidvar A, et al. A comparison of the effect of short-Term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis. Arch Gynecol Obstet 2011;284:105-10
86. Gopalkrishnan K, Katkam RR, Sachdeva G, et al. Effects of an antiprogestin onapristone on the endometrium of bonnet monkeys: Morphometric and ultrastructural studies. Biol Reprod 2003;68:1959-67 (Pubitemid 36686985)
87. Brenner RM, Slayden OD, Nath A, et al. Intrauterine administration of CDB-2914 (Ulipristal) suppresses the endometrium of rhesus macaques. Contraception 2010;81:336-42
88. Kettel LM, Murphy AA, Morales AJ, et al. Treatment of endometriosis with the antiprogesterone mifepristone (RU486). Fertil Steril 1996;65:23-8 (Pubitemid 26006643)
89. Kettel LM, Murphy AA, Morales AJ, et al. Preliminary report on the treatment of endometriosis with low-Dose mifepristone (RU 486). Am J Obstet Gynecol 1998;178:1151-6 (Pubitemid 28304614)
90. Laschke MW, Menger MD. Anti-Angiogenic treatment strategies for the therapy of endometriosis. Hum Reprod Update 2012;18:682-702
91. Hill JA, Haimovici F, Anderson DJ. Products of activated lymphocytes and macrophages inhibit mouse embryo development in vitro. J Immunol 1987;139:2250-4 (Pubitemid 17152118)
92. Koninckx PR, Craessaerts M, Timmerman D, et al. Anti-TNF-Alpha treatment for deep endometriosisassociated pain: A randomized placebocontrolled trial. Hum Reprod 2008;23(9):2017-23
93. Marques LJ, Zheng L, Poulakis N, et al. Pentoxifylline inhibits TNF-Alpha production from human alveolar macrophages. Am J Respir Crit Care Med 1999;159:508-11 (Pubitemid 29084873)
94. Nothnick WB, Curry TE, Vernon MW. Immunomodulation of rat endometriotic implant growth and protein production. Am J Reprod Immunol 1994;31:151-62 (Pubitemid 24149361)
95. Lv D, Song H, Li Y, et al. Pentoxifylline versus medical therapies for subfertile women with endometriosis. Cochrane Database Syst Rev 2009;CD007677
96. Balasch J, Creus M, Fabregues F, et al. Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: A pilot randomized clinical trial. Hum Reprod 1997;12:2046-50 (Pubitemid 27462490)
97. Alborzi S, Ghotbi S, Parsanezhad ME, et al. Pentoxifylline therapy after laparoscopic surgery for different stages of endometriosis: A prospective, double-blind, randomized, placebo-Controlled study. J Minim Invasive Gynecol 2007;14:54-8 (Pubitemid 46049099)
98. Creus M, Fabregues F, Carmona F, et al. Combined laparoscopic surgery and pentoxifylline therapy for treatment of endometriosis-Associated infertility: A preliminary trial. Hum Reprod 2008;23:1910-16 (Pubitemid 352020005)
99. Kamencic H, Thiel JA. Pentoxifylline after conservative surgery for endometriosis: A randomized, controlled trial. J Minim Invasive Gynecol 2008;15:62-6 (Pubitemid 351199832)
100. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007;356:2457-71 (Pubitemid 46919772)
101. Bulun SE, Cheng YH, Pavone ME, et al. Estrogen receptor-beta, estrogen receptor-Alpha, and progesterone resistance in endometriosis. Semin Reprod Med 2010;28:36-43
102. Boonyaratanakornkit V. Scaffolding proteins mediating membrane-initiated extranuclear actions of estrogen receptor. Steroids 2011;76(9):877-84
103. Lu Q, Pallas DC, Surks HK, et al. Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha. Proc Natl Acad Sci USA 2004;101(49):17126-31 (Pubitemid 39627785)
104. Ngo C, Chereau C, Nicco C, et al. Reactive oxygen species controls endometriosis progression. Am J Pathol 2009;175:225-34
105. Leconte M, Nicco C, Ngo C, et al. The mTOR/AKT inhibitor temsirolimus prevents deep infiltrating endometriosis in mice. Am J Pathol 2011;179:880-9
106. Leconte M, Nicco C, Ngo C, et al. Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis. Am J Pathol 2010;177:2963-70
107. Halme J, Becker S, Haskill S. Altered maturation and function of peritoneal macrophages: Possible role in pathogenesis of endometriosis. Am J Obstet Gynecol 1987;156:783-9 (Pubitemid 17058777)
108. Halme J, White C, Kauma S, et al. Peritoneal macrophages from patients with endometriosis release growth factor activity in vitro. J Clin Endocrinol Metab 1988;66:1044-9
109. Ngo C, Nicco C, Leconte M, et al. Antiproliferative effects of anastrozole, methotrexate, and 5-fluorouracil on endometriosis in vitro and in vivo. Fertil Steril 2010 ;94(5):1632-8 ; e1
110. Ngo C, Nicco C, Leconte M, et al. Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo. J Pathol 2010;222:148-57
111. Dooley A, Bruckdorfer KR, Abraham DJ. Modulation of fibrosis in systemic sclerosis by nitric oxide and antioxidants. Cardiol Res Pract 2012 ;2012:521958
112. Yotova IY, Quan P, Leditznig N, et al. Abnormal activation of Ras/Raf/MAPK and RhoA/ROCKII signalling pathways in eutopic endometrial stromal cells of patients with endometriosis. Hum Reprod 2011;26:885-97
113. Santulli P, Marcellin L, Noel JC, et al. Sphingosine pathway deregulation in endometriotic tissues. Fertil Steril 2012;97:904-11
114. Meldrum DR, Chang RJ, Lu J, et al. "Medical oophorectomy" using a long-Acting GNRH agonist-A possible new approach to the treatment of endometriosis. J Clin Endocrinol Metab 1982;54:1081-3 (Pubitemid 13243727)
115. Steingold KA, Cedars M, Lu JK, et al. Treatment of endometriosis with a long-Acting gonadotropin-releasing hormone agonist. Obstet Gynecol 1987;69:403-11 (Pubitemid 17027477)
116. Schriock E, Monroe SE, Henzl M, et al. Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin). Fertil Steril 1985;44:583-8 (Pubitemid 16199646)
117. Miller JD, Shaw RW, Casper RF, et al. Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin-releasing hormone agonist. Fertil Steril 1998;70:293-6 (Pubitemid 28361484)
118. Paoletti AM, Serra GG, Cagnacci A, et al. Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment. Fertil Steril 1996;65:707-10 (Pubitemid 26096905)
119. Cedars MI, Lu JK, Meldrum DR, et al. Treatment of endometriosis with a long-Acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate. Obstet Gynecol 1990;75:641-5 (Pubitemid 20110183)
120. Surrey ES, Gambone JC, Lu JK, et al. The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis. Fertil Steril 1990;53:620-6 (Pubitemid 20143041)
121. Kiilholma P, Tuimala R, Kivinen S, et al. Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen addback therapy in the treatment of endometriosis. Fertil Steril 1995;64:903-8
122. Moghissi KS, Schlaff WD, Olive DL, et al. Goserelin acetate (Zoladex) with or without hormone replacement therapy for the treatment of endometriosis. Fertil Steril 1998;69:1056-62 (Pubitemid 28274893)
123. Surrey ES, Silverberg KM, Surrey MW, et al. Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril 2002;78:699-704
124. Maia H Jr, Casoy J, Correia T, et al. The effect of oral contraceptives on aromatase expression in the eutopic endometrium of patients with endometriosis. Gynecol Endocrinol 2008;24:123-8 (Pubitemid 351365857)
125. Tokushige N, Markham R, Russell P, et al. High density of small nerve fibres in the functional layer of the endometrium in women with endometriosis. Hum Reprod 2006;21:782-7 (Pubitemid 43372988)
126. Tokushige N, Markham R, Russell P, et al. Effects of hormonal treatment on nerve fibers in endometrium and myometrium in women with endometriosis. Fertil Steril 2008;90:1589-98
127. Pavone ME, Bulun SE. Aromatase inhibitors for the treatment of endometriosis. Fertil Steril 2012
128. Ferrero S, Venturini PL, Ragni N, et al. Pharmacological treatment of endometriosis: Experience with aromatase inhibitors. Drugs 2009;69:943-52
129. Novella-Maestre E, Carda C, Noguera I, et al. Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis. Hum Reprod 2009;24:1025-35